Finland· FI-REL-REL23976
Plasmalyte
A elektrolytlösungen product containing sodium chloride + potassium chloride + magnesium chloride hexahydrate + sodium acetate trihydrate + 1 more, registered in Finland by Baxter Oy. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Elektrolytlösungen is registered in 12 of 19 countries.
Countries holding a registration under ATC B05BB01 (elektrolytlösungen), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Elektrolytlösungen · ATC B05BB01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Sodium chloride + Potassium chloride + Magnesium chloride hexahydrate + Sodium acetate trihydrate + 1 more
- Manufacturer
- Baxter Oy
- Country
- Finland (FI)
- ATC code
- B05BB01
- ATC class
- Elektrolytlösungen
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
112 interactions on record for elektrolytlösungen.
Graded by severity as the source publishes them — 27 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Elektrolytlösungen · interactions on record
112 records
- 27 moderate
- 12 minor
Most severe, free to view
- Acetylsalicylic acidB01AC06moderate
- QuinidineC01BA01moderate
- EphedrineC01CA26moderate
- EphedrinC01CB01moderate
73 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Elektrolytlösungen in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesIsolyte SB. Braun Medical Inc.
- CzechiaISOLYTEFresenius Kabi s.r.o., Praha
- FranceIONOVEN, solution pour perfusionFRESENIUS KABI FRANCE
- IrelandIonolyte solution for infusionFresenius Kabi Deutschland GmbH
- CanadaISOLYTE S (MULTI-ELECTROLYTE INJECTION)B. BRAUN MEDICAL INC
- IcelandPlasmalyteBaxter Medical AB*
- NorwayPlasmalyteBaxter Medical AB
- United KingdomPotassium chloride 0.15% (potassium 20mmol/1litre) / Magnesium chloride 0.2% (magnesium 10mmol/1litre) / Sodium chloride 0.9% infusion 1litre bagsSpecial Order
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Elonorm, Plasmalyt
- Belgium · Ionolyte, Plasmalyte A Viaflo
- Bulgaria · Плазма-Лайт 148 (Ph 7,4)
- Cyprus · Ionolyte, Plasma-Lyte 148
- Czechia · Isolyte, Plasmalyte
- Denmark · Plasmalyte
- Spain · Ionolyte, Viaflo Plasmalyte 148 (Ph 7,4)
- France · Ionoven, Plasmalyte Viaflo
- United Kingdom (Northern Ireland) · Ionolyte, Plasma-Lyte 148
- Greece · Ionolyte, Plasma-Lyte 148 (Ph 7,4)
- Croatia · Ionolyte, Plasma-Lyte 148 (Ph 7,4) Viaflo
- Hungary · Isolyte
- Ireland · Ionolyte, Plasma-Lyte 148 (Ph 7.4)
- Iceland · Plasmalyte
- Italy · Crystalsol, Elettrolitica Di Reintegrazione Con Sodio Gluconato
- Lithuania · Plasmalyte
- Luxembourg · Plasmalyte A Viaflo
- Malta · Ionolyte, Plasma-Lyte 148 (Ph 7.4)
- Netherlands · Ionolyte, Plasma-Lyte 148
- Norway · Plasmalyte
- Poland · Plasmalyte, Venolyte
- Portugal · Ionolyte, Plasma-Lyte 148, Viaflo
- Romania · Ionolyte, Plasmalyte
- Sweden · Plasmalyte
- Slovenia · Ionolyte, Plaslyte
- Slovakia · Isolyte, Plasmalyte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0b9632f0-d531-432a-bb5e-566ba3e9b971 GET /v1/drugs/0b9632f0-d531-432a-bb5e-566ba3e9b971?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "infuusioneste, liuos",
"route": "Laskimoon",
"ddd_unit": null,
"strength": null,
"atc_label": "elektrolyytit",
"ma_number": "20946",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL23976",
"authorised_at": "2006-03-06"
}See everything about elektrolytlösungen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.